S 8678 New York Senate · 2025 Regular Session

Expands Medicaid coverage to include pharmacological treatment for hyperhidrosis

Summary

Expands Medicaid coverage to include pharmacological treatment for hyperhidrosis when such treatment is ordered by a physician, registered physician assistant, or registered nurse practitioner; provides that the provisions shall not take effect unless all necessary approvals under federal law and regulation have been obtained to receive federal financial participation in the costs.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Jan 2026

Committee Review

Floor Vote

Governor

Introduced Jan 7, 2026 Last action Apr 29, 2026

Maddy AI version diff · 1 comparison

What changed between versions

S8678 → S8678A · 2 edits

MINOR

The bill was amended to add three new co-sponsors (Senators Addabbo, Ramos, and Scarcella-Spanton) and updated the effective date of the new Medicaid coverage for hyperhidrosis treatment from a standard 180-day waiting period to April 1, 2027. This change accelerates the implementation of the pharmacological treatment benefits, ensuring patients can access care sooner than originally planned.

Scope change

The bill's scope of applicability remains focused on expanding Medicaid coverage for hyperhidrosis, but the timeline for when this coverage becomes active has been modified.

SCOPE

Three additional Senators (Addabbo, Ramos, and Scarcella-Spanton) were added to the list of bill sponsors.

TIMELINE

The effective date for the new Medicaid coverage was changed from '180 days after becoming law' to a fixed date of 'April 1, 2027'.

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Apr 29, 2026

Upper · Passed

PRINT NUMBER 8678A

upper

Apr 29, 2026

Upper · Passed

AMEND AND RECOMMIT TO HEALTH

upper

Jan 7, 2026

Committee

REFERRED TO HEALTH

upper

1 primary · 3 co-sponsors